Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 5, 2025PharmaceuticsOpen Access

Challenges and Innovations in Paediatric Brain Tumour Treatments

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNadia ShahJSJessica SohlMGMassimo Ganassi

Discussion

Loading...

Member takes

Overview

Review highlights targeted therapies and precision medicine in pediatric brain tumors, suggesting improved outcomes from clinical trials.

Key Points

  • Targeted therapies, including kinase inhibitors, represent an important advancement in pediatric brain tumor treatment.
  • Over the last decade, clinical trials have focused on interventions tailored to the specific biology of pediatric brain tumors.
  • Innovations in diagnostics, like molecular profiling, emphasize a move towards precision medicine for better treatment outcomes.
  • Long-term safety evaluations are essential to ensure that these novel therapeutic strategies benefit the quality of life for children.

Cite This Study

Shah et al. (2025) studied this question.

synapsesocial.com/papers/6932313d8e51979591dcefc1https://doi.org/10.3390/pharmaceutics17121561
View Full Paper
Ask AI
Bookmark
Share